SIM
PFE icon

Studio Investment Management’s Pfizer PFE Stock Holding History

Studio Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$908K Buy
37,694
+4,100
+12% +$107K 0.15% 92
2026
Q1 		$943K Buy
33,594
+1,149
+4% +$30.6K 0.17% 82
2025
Q4 		$808K Buy
32,445
+581
+2% +$14.7K 0.15% 95
2025
Q3 		$812K Buy
31,864
+1,765
+6% +$43.6K 0.15% 93
2025
Q2 		$730K Buy
30,099
+5,595
+23% +$130K 0.15% 94
2025
Q1 		$621K Buy
24,504
+13,430
+121% +$351K 0.13% 105
2024
Q4 		$294K Sell
11,074
-13,631
-55% -$370K 0.06% 147
2024
Q3 		$715K Sell
24,705
-200
-0.8% -$5.83K 0.15% 92
2024
Q2 		$697K Buy
24,905
+4,052
+19% +$112K 0.16% 89
2024
Q1 		$579K Sell
20,853
-88,787
-81% -$2.46M 0.14% 95
2023
Q4 		$3.16M Buy
109,640
+2,236
+2% +$67.6K 0.81% 41
2023
Q3 		$3.56M Buy
107,404
+22,284
+26% +$788K 0.99% 29
2023
Q2 		$3.12M Buy
85,120
+9,973
+13% +$388K 0.87% 34
2023
Q1 		$3.07M Sell
75,147
-1,273
-2% -$55K 0.93% 29
2022
Q4 		$3.92M Sell
76,420
-665
-0.9% -$31.9K 1.27% 25
2022
Q3 		$3.37M Sell
77,085
-2,955
-4% -$144K 1.21% 21
2022
Q2 		$4.2M Sell
80,040
-2,405
-3% -$123K 1.46% 17
2022
Q1 		$4.27M Sell
82,445
-270
-0.3% -$14K 1.41% 15
2021
Q4 		$4.88M Sell
82,715
-860
-1% -$42.6K 1.76% 12
2021
Q3 		$3.6M Buy
+83,575
New +$3.7M 1.54% 15

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Studio Investment Management's PFE Position: Q2 2026 in Review

Studio Investment Management increased its Pfizer (PFE) stake by 12% in Q2 2026, buying an estimated $107K and bringing the position to 37,694 shares worth $908K. The position accounts for 0.15% of the portfolio, ranked #92.

Studio Investment Management first reported a position in PFE in Q3 2021 and has held it in 20 quarters since. The position peaked at $4.88M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Studio Investment Management held 37,694 shares of Pfizer worth $908K as of Q2 2026.
  • Studio Investment Management bought 4,100 Pfizer shares in Q2 2026, an estimated $107K.
  • Pfizer made up 0.15% of Studio Investment Management's portfolio in Q2 2026, its #92 holding.
  • Studio Investment Management first reported a position in Pfizer in Q3 2021 and has held it in 20 quarters since.
  • Studio Investment Management's Pfizer position peaked at $4.88M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Studio Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.